Pieris Pharmaceuticals (NASDAQ:PIRS) Receives New Coverage from Analysts at StockNews com themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
StockNews.com began coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a report published on Saturday. The firm issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Trading Up 8.3 % Shares of PIRS opened at $0.17 on Friday. The company’s fifty day simple moving average is $0.17 and its 200-day […]
StockNews.com began coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a research note issued to investors on Wednesday. The firm issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Price Performance NASDAQ:PIRS opened at $0.16 on Wednesday. The business’s 50-day moving average is $0.18 and its two-hundred day moving average […]
StockNews.com assumed coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a research report released on Wednesday morning. The firm issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Stock Performance Shares of NASDAQ:PIRS opened at $0.16 on Wednesday. The stock has a fifty day simple moving average of $0.18 and […]
StockNews.com began coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a research report released on Tuesday morning. The firm issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Stock Performance Shares of Pieris Pharmaceuticals stock opened at $0.17 on Tuesday. The business’s 50-day moving average price is $0.19 and its […]